Universal Ibogaine Inc.

TSXV:IBO Stock Report

Market Cap: CA$3.1m

Universal Ibogaine Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Nick Karos

Chief executive officer

CA$240.0k

Total compensation

CEO salary percentage100.0%
CEO tenure2.9yrs
CEO ownership0.4%
Management average tenureno data
Board average tenure1.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Nick Karos's remuneration changed compared to Universal Ibogaine's earnings?
DateTotal CompensationSalaryCompany Earnings
Apr 30 2024n/an/a

-CA$2m

Jan 31 2024n/an/a

-CA$1m

Oct 31 2023n/an/a

-CA$2m

Jul 31 2023CA$240kCA$240k

-CA$2m

Apr 30 2023n/an/a

-CA$6m

Jan 31 2023n/an/a

-CA$7m

Oct 31 2022n/an/a

-CA$7m

Jul 31 2022CA$235kCA$140k

-CA$10m

Compensation vs Market: Nick's total compensation ($USD167.01K) is about average for companies of similar size in the Canadian market ($USD164.07K).

Compensation vs Earnings: Nick's compensation has increased whilst the company is unprofitable.

CEO

Nick Karos

2.9yrs

Tenure

CA$240,000

Compensation

Mr. Nicholas Peter Karos, also known as Nick, is Chief Executive Officer of Universal Ibogaine Inc. from January 10, 2022, serves as its Director of Capital Markets since January 2022 and serves as its Dir...

Board Members

NamePositionTenureCompensationOwnership
Nicholas Karos
CEO, Director of Capital Markets & Director2.3yrsCA$240.00k0.39%
CA$ 12.0k
James Duncan
Independent Director1.2yrsno datano data
Melissa Lavasani
Member of Advisory Board1.6yrsno datano data
Marcos Moura
Member of Advisory Board1.6yrsno datano data
Travis Hayes
Member of Advisory Board1.6yrsno datano data
Jerry Daniels
Member of Advisory Board1.6yrsno datano data
Candice Wilson
Member of Advisory Board1.6yrsno datano data
Amanda Zinter
Member of Advisory Board1.6yrsno datano data
Dean Koumontzis
Independent Director1.2yrsno data0.065%
CA$ 2.0k
Ken Cranwill
Independent Directorless than a yearno data8.75%
CA$ 270.0k

1.6yrs

Average Tenure

Experienced Board: IBO's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:22
End of Day Share Price 2024/12/20 00:00
Earnings2024/04/30
Annual Earnings2023/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Universal Ibogaine Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution